← FDA Drug Approvals (Drugs@FDA)
TAZAROTENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2025-11-24
Drug application
- FDA Application #
ANDA214560- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TAZAROTENE
- Generic name
- Tazarotene
- Active ingredients
- TAZAROTENE
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- SOLARIS PHARMA CORP
- First approval
- 2025-11-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown